A citation-based method for searching scientific literature

Inhibitors of bromodomain and extra-terminal proteins for treating multiple human diseases.
Ewelina Kulikowski, Brooke D Rakai, Norman C W Wong. Med Res Rev 2021
Times Cited: 45



Novel strategies targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery.
Dailin Liang, Yifan Yu, Zonghui Ma. Eur J Med Chem 2020
Times Cited: 23




List of shared articles



Times cited

Targeting Bromodomain-Selective Inhibitors of BET Proteins in Drug Discovery and Development.
Juncheng Chen, Pan Tang, Yuxi Wang, Jiaxing Wang, Chengcan Yang, Yang Li, Gaoxia Yang, Fengbo Wu, Jifa Zhang, Liang Ouyang. J Med Chem 2022
2

BRD4: An emerging prospective therapeutic target in glioma.
Hua Yang, Li Wei, Yang Xun, Anping Yang, Hua You. Mol Ther Oncolytics 2021
16

Discovery of 2-((2-methylbenzyl)thio)-6-oxo-4-(3,4,5-trimethoxyphenyl)-1,6-dihydropyrimidine-5-carbonitrile as a novel and effective bromodomain and extra-terminal (BET) inhibitor for the treatment of sepsis.
Xuetao Chen, Fanying Meng, Jingtian Zhang, Zijian Zhang, Xuan Ye, Weikun Zhang, Yuanyuan Tong, Xinrui Ji, Rujun Xu, Xiao-Li Xu,[...]. Eur J Med Chem 2022
0

Novel Bromodomain BRD4 Inhibitors for Treating Cancer.
Ram W Sabnis. ACS Med Chem Lett 2021
6

Novel Bromodomain Inhibitors for Treating Cancer, Fibrosis, and Inflammatory Disorders.
Ram W Sabnis. ACS Med Chem Lett 2021
6

Tumor-Targeted Bivalent Protein Degradation for Application in Cancer Therapy.
Robert B Kargbo. ACS Med Chem Lett 2021
1


Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy